Stocks / NASDAQ / Mateon Therapeutics, Inc.

Mateon Therapeutics, Inc.

Our Opinion

Mateon Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“These results add to previously published data obtained with fosbretabulin which demonstrate in an animal study significant single-agent anti-leukemic action of OXiGENE’s VDAs.” Read the following article

Company Description

Mateon Therapeutics, Inc. is a biopharmaceutical company, which focus on the development of vascular disrupting agents, or VDAs, for the treatment of cancer. It products include VDAs-CA4P and OXi4503. The company was founded in 1988 and is headquartered in South San Francisco, CA. [Source: MarketWatch]

Company Website: https://www.mateon.com